Innovative Lifesciences Private Limited, a active private limited company, was established on 03 February 2012 in Panchkula, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232HR2012PTC065919. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.40 M.
Formerly known as C.I.T. Biosciences Private Limited, Omnibus Militia Private Limited. It upholds a compliant status. Its leadership includes Rohit Jangwan (Director), Ankit (Director). Past directors included Jagjit Singh, Swarn Singh, Neelam Devi. It holds no open charges and ₹2.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 4, 2Nd Floor Swastik Vihar, Mdc, Sector 5, Panchkula, Haryana, 134114.
U24232HR2012PTC065919
065919
03 February 2012
₹0.50 M
₹0.40 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Innovative Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohit Jangwan | Director | 09 Nov 2015 | Current |
| Ankit | Director | 11 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Dec 2014 | Past |
| Pramod Abcsdd | Additional Director | 22 Sep 2015 | Past |
| Pramod Abcsdd | Director | 12 Nov 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 12 Jan 2019 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Innovative Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 10.42% decrease. The company also saw a slight decrease in profitability, with a 5.36% decrease in profit. The company's net worth Soared by an impressive increase of 49.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Innovative Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Feb 2016 | Others | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Innovative Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Innovative Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovative Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Innovative Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Innovative Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on A charge registered on 02 Feb 2016 via Charge ID 100034286 with Others was fully satisfied on 11 Feb 2019. was documented.
Progress on Ankit was appointed as a Director was appointed as a Director on 11 Jan 2019 & has been associated with this company since 6 years 10 months . was documented.
A charge with Others amounted to Rs. 2.50 M with Charge ID 100034286 was registered on 02 Feb 2016. was recorded as a recent event.
Rohit Jangwan was appointed as a Director was appointed as a Director on 09 Nov 2015 & has been associated with this company since 10 years 22 days . was recorded as a recent event.
The CIN of Innovative Lifesciences Private Limited is U24232HR2012PTC065919.
Innovative Lifesciences Private Limited is headquartered at Sco 4, 2Nd Floor Swastik Vihar, Mdc, Sector 5, Panchkula, Haryana, 134114.
Innovative Lifesciences Private Limited was incorporated on 03 February 2012.
The current directors of Innovative Lifesciences Private Limited are
The primary industry of Innovative Lifesciences Private Limited is Trade.
Innovative Lifesciences Private Limited is unlisted.
The authorized capital of Innovative Lifesciences Private Limited is ₹0.50 M, and the paid-up capital is ₹0.40 M.
The compliance status of Innovative Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX